Search research articles
Contact Us
Filters
Showing results (41-50 of 121) with videos related to
Page
of 13
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 25, 2021
Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A
Andreas Tiede, Kingsley Hampton, Victor Jiménez-Yuste, et al.
Viruses
|
August 26, 2022
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
Victoria Panagiota, Christiane Dobbelstein, Sonja Werwitzke, et al.
Thrombosis and Haemostasis
|
February 3, 2026
Pharmacodynamic interaction between emicizumab and coagulation Factor VIII
Matthias Chill, Emma Louise Konarski, Annika Klingberg, et al.
Journal of Blood Medicine
|
November 10, 2021
Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A
Parth Vashi, Katharine Batt, Robert Klamroth, et al.
Acta Haematologica
|
January 27, 2022
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
Matthias Höpting, Ulrich Budde, Andreas Tiede, et al.
Blood
|
August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
Elena Santagostino, Claude Negrier, Robert Klamroth, et al.
Seminars in Thrombosis and Hemostasis
|
September 14, 2013
Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats
Giovanni Di Minno, Mariana Canaro, James W Ironside, et al.
Haematologica
|
October 5, 2013
Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice
Giovanni Di Minno, Mariana Canaro, James W Ironside, et al.
Thrombosis and Haemostasis
|
August 7, 2015
Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro
Sonja Werwitzke, Nadine Vollack, Marcus von Hornung, et al.
Blood Reviews
|
September 19, 2015
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders
Giovanni Di Minno, Carlo Federico Perno, Andreas Tiede, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 121) with videos related to
Sort By:
Page
of 13
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 25, 2021
Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A
Andreas Tiede, Kingsley Hampton, Victor Jiménez-Yuste, et al.
Viruses
|
August 26, 2022
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
Victoria Panagiota, Christiane Dobbelstein, Sonja Werwitzke, et al.
Thrombosis and Haemostasis
|
February 3, 2026
Pharmacodynamic interaction between emicizumab and coagulation Factor VIII
Matthias Chill, Emma Louise Konarski, Annika Klingberg, et al.
Journal of Blood Medicine
|
November 10, 2021
Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A
Parth Vashi, Katharine Batt, Robert Klamroth, et al.
Acta Haematologica
|
January 27, 2022
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
Matthias Höpting, Ulrich Budde, Andreas Tiede, et al.
Blood
|
August 4, 2012
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
Elena Santagostino, Claude Negrier, Robert Klamroth, et al.
Seminars in Thrombosis and Hemostasis
|
September 14, 2013
Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats
Giovanni Di Minno, Mariana Canaro, James W Ironside, et al.
Haematologica
|
October 5, 2013
Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice
Giovanni Di Minno, Mariana Canaro, James W Ironside, et al.
Thrombosis and Haemostasis
|
August 7, 2015
Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro
Sonja Werwitzke, Nadine Vollack, Marcus von Hornung, et al.
Blood Reviews
|
September 19, 2015
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders
Giovanni Di Minno, Carlo Federico Perno, Andreas Tiede, et al.
Page
of 13